论文部分内容阅读
目的观察岩舒注射液治疗中晚期肝癌的临床疗效。方法 84例中晚期肝癌分为两组,分别采用静脉点滴岩舒注射液加支持治疗和单纯支持治疗。对两组肿瘤大小、体力状况、生存率等进行评价。结果肿瘤控制率:对照组9.6%,治疗组32.6%;血AFP值下降比较:对照组0;治疗组40.9%,其中下降50%占18.2%。Karnofsky评分上升加稳定,对照组为21.9%,治疗组为41.9%。治疗组生存率也明显高于对照组,两组差异有显著性(P<0.05)。结论岩舒注射液治疗中晚期肝癌,在改善生活质量、延长生存时间、控制肿瘤生长等方面明显好于对照组,值得在临床推广。
Objective To observe the clinical efficacy of Yan Shu injection in the treatment of advanced liver cancer. Methods 84 cases of advanced liver cancer were divided into two groups, respectively, intravenous drip Yan Shu injection plus supportive therapy and simple supportive treatment. The two groups of tumor size, physical status, survival rates were evaluated. Results The tumor control rate was 9.6% in the control group and 32.6% in the treatment group. The blood AFP value decreased compared with 0 in the control group and 40.9% in the treatment group, with a decrease of 50% in 18.2%. Karnofsky score increased and stabilized, the control group was 21.9%, the treatment group was 41.9%. The treatment group survival rate was significantly higher than the control group, the difference between the two groups was significant (P <0.05). Conclusion Yanshu injection in the treatment of advanced hepatocellular carcinoma is better than the control group in improving quality of life, prolonging survival time and controlling tumor growth, which is worthy of clinical promotion.